Coya Therapeutics, Inc.·4

Aug 19, 4:01 PM ET

GOLDSTEIN DOV A MD 4

4 · Coya Therapeutics, Inc. · Filed Aug 19, 2025

Insider Transaction Report

Form 4
Period: 2025-08-18
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2025-08-18$1.09/sh+17,557$19,13727,557 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-08-1817,5570 total
    Exercise: $1.09From: 2021-04-01Exp: 2031-03-30Common Stock (17,557 underlying)
Footnotes (1)
  • [F1]This option is fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4